Milestone Pharmaceuticals Inc., was incorporated under the laws of Quebec in July 2003. The company is a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular drugs. The company's approved product, CARDAYSTTM (Eltrapamil) nasal spray, is marketed in the United States and is the first and only self-therapeutic drug approved by the U.S. Food and Drug Administration for use by patients anytime, anywhere. The company continues to seek marketing approval from regulators responsible outside the United States, either directly or through cooperation with partners. The company is also developing Eltropamil, or "AFib-RVR," for the rapid ventricular rate atrial fibrillation indication.
